Health ❯Cardiovascular Diseases ❯Prevention and Treatment ❯Drug Therapy
The Danish pharmaceutical giant's experimental drug, amycretin, demonstrates significant weight loss in early trials, potentially outperforming its predecessors, Wegovy and Ozempic.
